Near-death Experience in ICU Survivors

March 24, 2022 updated by: Anne-Françoise Rousseau, University of Liege

Incidence of Near-death Experiences Among Patients Who Survived a Critical Illness

This observational study aims to describe the incidence of near-death experience (NDE) in patients who survived a critical illness. In order to help determine the potential risk factors of NDE, dissociative status and spirituality are also investigated. Finally, in patients who experienced NDE, a magnetic resonance imaging is performed to search for any structural modifications.

Study Overview

Study Type

Observational

Enrollment (Actual)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Liège, Belgium, 4000
        • University Hospital of Liege

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All consecutive patients who survive any critical illness without exclusion criteria may be assessed for NDE occurence

Description

Inclusion Criteria:

  • All consecutive patients who survived critical illness

Exclusion Criteria:

  • Glasgow Coma Scale < 15/15
  • Confusion (CAM ICU scale)
  • Refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NDE
Time Frame: Greyson questionnaire is administered during the week following ICU discharge
NDE occurence during ICU stay, retrospectively detected by the Greyson scale. Greyson scale is a 16 items and 32 points scale. Minimal score is 0, maximal score is 32. A NDE is suspected when score is equal or higher than 7.
Greyson questionnaire is administered during the week following ICU discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life estimation
Time Frame: one year after first interview
Quality of life assessment, using EQ-5D-3L
one year after first interview
NDE
Time Frame: one year after first interview
NDE occurence during ICU stay, retrospectively detected by the Greyson scale.
one year after first interview
MCQ (Memory Characteristics Questionnaire)
Time Frame: one month after first interview
analyze of the phenomenological characteristics of real and imagined memories
one month after first interview

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne-Françoise Rousseau, MD, PhD, University Hospital of Liege

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2019

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

February 19, 2020

First Submitted That Met QC Criteria

February 19, 2020

First Posted (Actual)

February 21, 2020

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

March 24, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EMISI

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Greyson NDE scale

3
Subscribe